Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

K-ras oncogene mutations indicate malignancy in cystic tumors of the pancreas.

Annals of surgery - 1 Jul 1998

Bartsch D, Bastian D, Barth P, Schudy A, Nies C, Kisker O, Wagner H J, Rothmund M

Abstract excerpt

OBJECTIVE: To evaluate clinical parameters, presurgical diagnostic tests, histologic findings, and the presence of K-ras oncogene mutations in cystic tumors of the pancreas to determine which best predict malignancy. SUMMARY BACKGROUND DATA: Because presurgical, intraoperative, and final pathologic differentiation is difficult in cystic tumors of the pancreas, it would be a major benefit to identify markers that...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Prognosis
Share to Aged
Share to DNA Mutational Analysis

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to DNA, Neoplasm

Share to Genes, ras

Share to Mutation

Share to Pancreatic Neoplasms

Share to Polymerase Chain Reaction

Source

Open in PubMed Open full text

Identifiers

PMID: 9671070
DOI: 10.1097/00000658-199807000-00012
PMCID: PMC1191431

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

K-ras oncogene mutations indicate malignancy in cystic tumors of the pancreas.PMID 9671070Read ↗

K-ras mutations correlate with atypical cytology and elevated CEA levels in pancreatic cystic neoplasms.Semantic proximity Read ↗

Integration of KRAS testing in the diagnosis of pancreatic cystic lesions: a clinical experience of 618 pancreatic cysts.Semantic proximity Read ↗

Clinical Impact of KRAS and GNAS Analysis Added to CEA and Cytology in Pancreatic Cystic Fluid Obtained by EUS-FNA.Semantic proximity Read ↗

Diagnostic value of K-ras mutation analysis for pancreaticobiliary cytology specimens with indeterminate diagnosis.Semantic proximity Read ↗

Preoperative GNAS and KRAS testing in the diagnosis of pancreatic mucinous cysts.Semantic proximity Read ↗

Kras mutation analysis of fine needle aspirate under EUS guidance facilitates risk stratification of patients with pancreatic mass.Semantic proximity Read ↗

Utility of commercial DNA analysis in detecting malignancy within pancreatic cysts.Semantic proximity Read ↗

Diagnostic utility of K-ras mutational analysis on bile obtained by endoscopic retrograde cholangiopancreatography.Semantic proximity Read ↗

K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.Semantic proximity Read ↗

Sequential accumulation of K-ras mutations and p53 overexpression in the progression of pancreatic mucinous cystic neoplasms to malignancy.Semantic proximity Read ↗

K-ras mutational status in cytohistological tissue as a molecular marker for the diagnosis of pancreatic cancer: a systematic review and meta-analysis.Semantic proximity Read ↗

Diagnostic utility of K-ras mutations in fine-needle aspirates of pancreatic masses.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.